Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1/2 2

Status

Recruiting 4Not yet recruiting 2Withdrawn 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 2Breast 2

Conditions

Breast Neoplasms 5Neoplasms 4Neoplasm Metastasis 4Multiple Myeloma 3Lymphoma 3Leukemia 3Hematologic Neoplasms 3Triple Negative Breast Neoplasms 2Prostatic Neoplasms 2Ovarian Neoplasms 2Glioblastoma 2Fallopian Tube Neoplasms 2Urinary Bladder Neoplasms 1Recurrence 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Malignant Female Reproductive System Neoplasm 1Localized Head and Neck Carcinoma 1Leukemia, Myeloid, Acute 1Hematopoietic and Lymphoid System Neoplasm 1Gastrointestinal Neoplasms 1Fatigue 1Endometrial Neoplasms 1Depression 1Colonic Neoplasms 1Chemotherapy Effect 1Caregiver Burden 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Anxiety Disorders 1

Interventions

pembrolizumab 49Specimen Handling 29Magnetic Resonance Spectroscopy 25Biopsy 25Radiosurgery 17Gemcitabine 17Nivolumab 16Cyclophosphamide 14Cisplatin 14Paclitaxel 13Carboplatin 13Bevacizumab 13Leucovorin 11Irinotecan 11Fluorouracil 11Drug Therapy 11Taxes 10Radiotherapy 10Oxaliplatin 10Capecitabine 10trastuzumab deruxtecan 9fludarabine 9cemiplimab 8Doxorubicin 8Cetuximab 8abemaciclib 7Trastuzumab 7Pemetrexed 7Fulvestrant 7Docetaxel 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Neoplasm Metastasis × Palliative Care × Clear all
NCT07510802 2026-04-06

Dual-Target CAR-NK Cells for Advanced Breast Cancer HER2+ TNBC

Beijing Biotech

Phase 1/2 Recruiting
60 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT07486089 2026-03-20

DUAL-NK-BC

Beijing Biotech

Phase 1/2 Recruiting
60 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT07195513 2026-03-10

PRO-CONNECT

Dartmouth-Hitchcock Medical Center

Phase NA Recruiting
90 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT05947695 2023-09-13

Clinical Nurse Specialist Led Early Palliative Survivorship Care for Patients With Advanced Cancer

Good Samaritan Hospital Medical Center, New York

Phase NA Recruiting
100 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡